MAP Publication
ISPOR 2018 – Barcelona: Do Early Access schemes in the UK increase the likelihood of reimbursement and patient access?
Comparing success in achieving promising innovative medicine (PIM) status, gaining entry to the early access to medicines scheme (EAMS) and reimbursement in the UK.